Kate Grindlay Kelly, MSPH
As Project Director/Associate of the Free the Pill project at Ibis, Kate oversees the implementation of an ambitious program of work to move an oral contraceptive pill (OC) over the counter (OTC) in the United States. She also manages a portfolio of quantitative and qualitative social science research with a focus on improving reproductive health in underserved communities and exploring innovative approaches to increase reproductive health access. She has published and presented on reproductive health access for US servicewomen; the safety, effectiveness, and acceptability of telemedicine for medication abortion provision; and over-the-counter access to oral contraception, among other topics. Prior to joining Ibis, Kate worked for the University of California, San Francisco’s Women’s Global Health Imperative on the MIRA trial to evaluate the diaphragm as a possible method of female-controlled HIV and STI prevention. She left UCSF in 2007 to pursue an MSc degree in Public Health at Harvard University, and has been at Ibis since graduating in 2009.